Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 38

ПЕРЕДОВАЯ СТАТЬЯ2018

PHARMACOLOGICAL TREATMENT OF PARKINSON’S DISEASE: MOLECULAR ASPECTS AND PROSPECTS

Parkinson’s disease (PD) is a progressive, age-related, neuronal disorder that affects as much as 1% of the persons over 65 years. According to forecasts of the World Health Organization over the world about 9 million people will suffer from PD by 2030. So PD …

10.29296/24999490-2018-02-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017

THE ALTERATIONS OF AURKA GENE IN PATIENTS WITH GASTRIC CANCER AND MULTIPLE PRIMARY TUMORS

Introduction. Recent reports have demonstrated patients with malignant neoplasias have different molecular genetic aberrations. But there are few data available concerning patients with multiple primary tumors (MPT). Aim. To study molecular genetic alterations…

Details ↗
ОБЗОР2016

INHIBITORS OF CARBOHYDRATE METABOLISM IN CANCER THERAPY

Energy supply of cells can be provided through both an oxygen-dependent pathway of mitochondrial oxidative phosphorylation and oxygenindependent glycolysis. Oxidative phosphorylation in the synthesis of ATP is more efficient than in glycolysis, and respectivel…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

MOLECULAR GENETIC AND PHENOTYPIC CHARACTERISTICS OF PATIENTS WITH LUNG ADENOCARCINOMA AMONG INHABITANTS OF THE SOUTH OF RUSSIA

Introduction. EGFR mutation and EML4-ALK fusion are the most clinically significant genetic alterations in non-small cell lung cancer. Numerous studies have been devoted to EGFR mutations and their association with phenotypic clinical and pathological characte…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

RANK/RANKL/OPG SYSTEM COMPONENTS AND INTERLEUKINS 6, 8 16 IN BLOOD SERUM OF PATIENTS WITH PRIMARY BONE NEOPLASMS

Introduction. RANK/RANKL/OPG ligand-receptor system is a key player in bone tissue homeostasis directly regulating osteoclast differentiation and osteolysis. Many pathologic processes imposed by impairments in bone remodeling including tumor growth and metasta…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

TO THE MECHANISM OF MYOCARDIAL REMODELING IN THE ACUTEST PHASE OF EXPERIMENTAL MYOCARDIAL INFARCTION

The purpose of research. The study of the features of the left ventricle remodeling in the acutest stage of experimental myocardial infarction and the possibility of the correction of detected injuries. Methods. Experimental myocardial infarction in rats was i…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

PREVALENCE OF CYP2C19 GENETIC POLYMORPHISMS IN RUSSIAN PATIENTS WITH PEPTIC ULCERS TREATED WITH PROTON PUMP INHIBITORS

Introduction. Cytochrome P-450 2C19 is the main isoenzyme responsible for the metabolism of proton pump inhibitors, the main group of drugs for treating stomach and duodenal ulcer. There are genetic differences that affect the activity of this enzyme: there ar…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

MOLECULAR MODELING, SYNTHESIS AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF MODERN HETEROMEROUS PEPTIDES WITH IMIDAZO[4,5-Е]BENZO[1,2-C;3,4-C’]DIFUROXAN FRAGMENT AS NEW INHIBITORS OF PLATELET AGGREGATION

Introduction. Cardiovascular diseases consistently occupy the first place among causes of death and disability in almost all developed countries. The main importance of this group of diseases have myocardial infarction. One of the causes of myocardial infarcti…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

EXPERIMENTAL STUDY OF ANTITUMOR ACTIVITY OF NEW NITRIC OXIDE SYNTHASE INHIBITOR T1023

Introduction. Activation of eNOS/sGC/cGMP-pathway is a common link in the development of angiogenic action of the majority of pro-angiogenic factors. In this regard, the chemical inhibition of NOS (Nitric Oxide Synthase) may cause a nonspecific angiostatic eff…

Details ↗
Research article2014

MOLECULAR GENETIC MARKERS OF NON-SMALL CELL LUNG CANCER

Lung cancer is one of the most common oncologic diseases in the world and the most frequent cause of the death from malignant neoplasms. Last decade’s studies revealed significant number of molecular events leading to the onset and development of non-small cel…

Details ↗
Research article2014

RESEARCH OF ANTINEOPLASTIC ACTIVITY OF CHIMERIC PEPTIDE P16_ANTP IN VIVO

Introduction. P16INK4a protein plays one of the key role in processes of cell proliferation, its inactivation is noted in a number of tumors of various localization. Restoration of the p16INK4a function in neoplastic cells may promote braking of division of tu…

Details ↗
Research article2013

ABNORMALITIES OF HEMOSTASIS AND THEIR PREVENTION IN CANCER PATIENTS

Venous thromboembolism (VTE) is a frequent complication associated with increased mortality in cancer patients. The basic role in pathogenesis of thrombotic complication in cancer patients is played by changes in the hemostatic system caused by the tumor itsel…

Details ↗ PDF
Research article2013

EGFR AND KRAS MUTATIONS IMPORTANT FOR NON-SMALL CELL LUNG CANCER TARGET THERAPY

Last successful results in target therapy of cancer were achieved with different tyrosine kinases inhibitors (TKI). Target therapy of non-small cell lung cancer (NSCLC) with EGFR inhibitors gefitinib and erlotinib is effective only in patients with somatic mut…

Details ↗ PDF

Article search and quick navigation

Navigation